Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reactogenicity, Safety and Immunogenicity of an Recombinant Universal Influenza Vaccine Uniflu in Healthy Volunteers From 18 to 60 Years Old

NCT03789539 is registered in ClinicalTrials.gov with VA Pharma Limited Liability Company as lead sponsor.

NCT NCT03789539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03789539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reactogenicity, Safety and Immunogenicity of an Recombinant Universal Influenza Vaccine Uniflu in Healthy Volunteers From 18 to 60 Years Old
Lead sponsor
VA Pharma Limited Liability Company
Phase
Phase 1
Overall status
Unknown status
Start date
June 2, 2018
Completion date
December 31, 2018
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

safety issues